Thursday, Jan. 12 ⁽¹⁰⁾

Engineering Principles of DBS and SCS in Clinical Practice: General Introduction and Emerging Concepts Featured

This exciting workshop will present engineering principles relevant to Spinal Cord Stimulation (SCS) and Deep Brain Stimulation (DBS). The target audience of this course is clinicians that currently utilize or are interested in incorporating SCS and or DBS technologies into their clinical practice. The field of neuromodulation is rapidly evolving, and several technologies are now clinically available. These systems have diverse lead and stimulator designs. It is not always clear how different designs or waveform parameters affect the neural response and corresponding efficacy of the stimulation. Therefore, the goal of this course is to provide clinicians with an overview of the engineering principles and biophysics relevant to SCS and DBS. This course will also present the current understanding of the physiological effects and mechanisms of action of standard and emerging forms of SCS and DBS. Furthermore, this course will describe the safety and regulatory issues that are critical to electrode design and stimulation parameters. During the morning session, academic engineers and clinicians will present principles relevant to SCS and DBS technologies. During the afternoon session, engineers and scientists from industry will describe engineering principles, best practices, and new approaches related to their specific technologies. In a third session held during the first day of the conference, we will present engineering principles relevant to emerging technologies and mechanisms of action of SCS and DBS. At the end of the course, attendees will have a better understanding of the physiological and technical factors that determine the neural response to SCS and DBS. The ultimate goal of this course is to provide attendees with knowledge that will aid in their clinical implementation of SCS and DBS technologies.

Advanced Practice Provider Course (NPs/PAs/Nurses) Featured

The course will provide advanced practice providers with an overview of topics in neuromodulation through lectures and interactive presentations. The material will be presented by physicians and APP faculty and will be relevant for anyone interested in or involved in the management of patients in pain management, neurosurgery, neurology, orthopedic or physical medicine, and rehabilitation practice.

Intrathecal Therapy: Cased-Based Learning

Intrathecal drug delivery is a well-established intervention for chronic pain and severe spasticity with over 3 decades of clinical use. While there is proven efficacy with this treatment approach, there are critical decision points in the management of patients who are considering this intervention as well as patients who are already implanted. This course will describe approaches for patient selection, trialing, implantation, post-implantation management, troubleshooting, and therapy optimization. Additionally, this program will provide hands-on learning stations to review some of the technical aspects of this therapy. Multiple medical specialists would find this course beneficial including neurology, neurosurgery, anesthesiology, and physical medicine and rehabilitation. This course will also be of interest to many allied health professionals such as physical therapy, occupational therapy, nursing, pharmacy, case management, and bioengineering.

Learning Objectives

• Understand the indications and contraindications for intrathecal therapy
• Describe management strategies for intrathecal therapy optimization and troubleshooting
• Demonstrate technical skills that are commonly employed in the management of patients with intrathecal drug delivery systems

Introduction

Michael F. Saulino, MD PhD
Erik Shaw, DO

Should intrathecal therapy be considered in this patient?

Gladstone McDowall, MD

What steps should be undertaken before implant?

Jay S. Grider, DO PhD MBA

How do I manage a patient in the perioperative phase?

Yawar Qadri, MD PhD

How do I initiate therapy and manage the patient initially after implant?

Hemant Kalia, MD MPH

How do I optimize the therapy in the implanted patient?

Erik Shaw, DO

How do I set up practice to provide this therapy?

Mehul Desai, MD

What do I do if a patient has a medical emergency?

Daniel Moon, MD MS

How do I evaluate a patient who is no longer appreciating benefit with the therapy?

Michael Saulino, MD PhD

I3: ECOSYSTEM of NEUROMODULATION: Real World Data (RWD) and Real World Evidence (RWE)

The Annual North American Neuromodulation Society (NANS) Invention, Investment, and Invigoration (I3) Forum is designed to provide a dynamic and interactive platform for the review and discussion of emerging topics, technologies, clinical applications, and socioeconomic issues. Clinicians, scientists, engineers, industry, and investors will all be present at the forum. This year, NANS I3 will focus on Real World Data (RWD) and Real World Evidence (RWE).

Presentations will highlight insights and allow us to discuss outcome measures, trial design and statistics of designing studies. This session will explore what is being done in various markets across the globe to reduce cost and facilitate innovation in the field of neuromodulation.